Check Claims Before You Publish

 Quick Explanation Copied

 Long Explanation

No verifiable Adamczyk authorship found in the supplied evidence. A claim-level audit of all 20 supplied records identified zero publications with Bożena Adamczyk listed as an author. The records instead trace to heterogeneous, apparently unrelated author groups: a Parkinson's transcriptomics reproducibility study from the Shamir lab (code deposited at GENEPARK; funded by the Israel Ministry of Health and Michael J. Fox Foundation) PD transcriptomics signature reproducibility study, a computational C. elegans salt-chemotaxis neural network model C. elegans neural chemotaxis model, SERS nanotechnology papers SERS protein detection with Ag nanocubes, neuroimaging reproducibility studies, and a 2026 multiverse-consensus metabolomics pipeline Multiverse-consensus metabolomics pipeline.

What the records do establish about reproducibility infrastructure (not Adamczyk). Two high-value records quantify reprocessability failures in public transcriptomics: only 27.3% of 3,631 GEO human disease RNA-seq series are usably covered by uniform compendia despite 94.1% having public raw reads, with DEE2 usable coverage collapsing to 3.4% from 30.2% presence GEO reprocessability audit, and GEOMeta's ~600,000 sample annotation release shows 96.59% disease and 96.95% tissue concordance with DiSignAtlas GEOMeta LLM annotation workflow.

What is missing for an Adamczyk verdict. No full bibliography, h-index, publication list, or raw evidence audit attributed to Bożena Adamczyk is included in the supplied records. Confirming or refuting authorship requires a direct author-provided bibliography, ORCID profile, or explicit paper-by-paper author assignment — none of which can be inferred from the current evidence set.

Reproducibility signal heat-map of the supplied corpus. Where reproducibility was explicitly scored, the corpus ranges from 7 to 9 — but none of it is attributable to Adamczyk. This plot is a corpus-level audit, not an author audit.

 BGPT Author Review

Scientific Quality

Cannot be assessed from the supplied records — no publication attributable to Bożena Adamczyk appears in the evidence corpus, which spans unrelated author groups across transcriptomics, computational neuroscience, SERS nanotechnology, neuroimaging, and metabolomics. The nominal score is a placeholder reflecting the absence of attributable evidence, not a judgment of the author. Any actual Adamczyk bibliography would need to be supplied directly to produce a meaningful scientific quality estimate.

Communication Quality

Unassessable. No writing authored by Bożena Adamczyk is present in the supplied records; no abstract, figure, or prose can be attributed. A placeholder score only.

Author Novelty

Unassessable — no Adamczyk-authored work in the corpus. The 7-9 novelty scores in the records belong to other authors' publications and cannot be transferred.

Scientific Rigor

Unassessable. The supplied evidence records document rigorous work by other authors (pre-registered frozen analysis plans, permutation tests, falsification criteria) but contain no Adamczyk authorship attribution, so no rigor estimate can be honestly assigned.